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Glucose infusion test: A new screening test for vascular access zero [5]. The high prevalence of access recirculation de-
recirculation. tected by the classic urea test [4] is indeed an artifact
Background. Vascular access recirculation is an important caused by errors in sampling procedures. In clinical prac-cause of diminished dialysis efficiency. We propose a new screen-
tice, these new methods are not widely used becauseing test based on glucose infusion as a tracer for recirculation.
they require specific and expensive devices. Thus, theMethods. The glucose infusion test (GIT) protocol com-
prises a basal blood sample (A) from the arterial port, a 5 mL urea test is still the most widespread, despite its limita-
bolus of 20% glucose into the venous chamber (time 0), followed tions [6, 7].
by a second sample (B) in four seconds (from 13 to 17 s with We have developed a new method based on a glucoseQB 300 mL/min) from the same port. The blood glucose level
venous infusion as a tracer of recirculation. Any increaseis determined at the bedside on A and B with a reflectance
in the arterial blood line glucose level suggests vascularphotometer (CV 1.8%). Interpretation of the test is straightfor-
ward: If B 5 A, there is no recirculation, whereas if B . A, access recirculation.
recirculation can be calculated from the regression equation: Glucose can be detected by a reflectometer at the
0.046 3 (B 2 A) 1 0.07, obtained from in vitro tests reproduc-
bedside, and does not require expensive devices. Theing artificial recirculation at 0, 5, and 10%. To validate this
glucose infusion test (GIT) adds low cost to the immedi-new method in vivo, we compared GIT and the urea test on
39 hemodialysis patients, obtaining a good correlation (r 5 acy of the results. It can be used in every dialysis unit
0.93). The two tests were considered positive (recirculation for periodic screening or for bedside evaluation in critical
present) when the lower 95% confidence intervals were more situations (for example, uncertain needle positions or
than zero.
suspected vascular stenosis).Results. Our patients were divided into two groups: those
with (22 out of 39, mean recirculation 11.8%) or without recir-
culation (17 out of 39, mean 0.06%). The urea test did not
METHODSrecognize 7 out of 22 patients because they had a small recircu-
lation below the urea test limit of detection. GIT protocol
Conclusions. GIT was more sensitive (detection limit 0.3%),
The GIT can be used in any type of two-needle dialyticsimpler, and immediate in showing the results than the urea
test. It is an accurate and low-cost technique for screening and treatment, with or without glucose in the dialysis solution.
follow-up of vascular access in a dialysis unit. Basal conditions. The blood pump should be at a stan-
dard 300 mL/min and minimal ultrafiltration.
New online devices based on electrical impedance [1], 1. Withdraw about 1 mL of blood (sample A) from
optical [2], and ultrasound [3] methods have clearly dis- the arterial port [we used the standard arterial port
tinguished effective vascular access recirculation from position about 50 cm (priming volume 7 mL) from
cardiopulmonary recirculation, showing that in a well- the leur-lock].
functioning vascular access, the recirculation is usually 2. Start the timer and inject a bolus of 20% glucose
into the venous drip chamber in four seconds [if
20% glucose is not available, the same glucose doseKey words: dialysis efficiency, urea test, vascular access, cardiopulmo-
nary recirculation. (1 g of glucose in 5 mL) can be prepared diluting 3
mL of 33% glucose with 2 mL saline].Received for publication July 2, 1999
3. At the 13th second, withdraw approximately 1 mLand in revised form November 12, 1999
Accepted for publication December 2, 1999 of blood (sample B) from the same port during four
seconds (from 13 to 17 s).Ó 2000 by the International Society of Nephrology
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4. Determine glucose on A and B by a reflectance arm, and seven central venous catheters. All patients
gave informed consent.photometer at the bedside.
The classic protocol of the stop-flow urea test wasResults. Interpretation is straightforward: There is no
modified by the insertion of a y connector plus a three-recirculation if there is no rise in the glucose level (B 5
way valve between the arterial needle and the blood lineA), but it is present if B is higher than A.
[8]. This reduced the arterial dead space to only 2 mL,
In vitro validation so the systemic sample (S) could be obtained quickly
after a good washout of 20 mL. This procedure (totalWe assessed the kinetics and reliability of GIT by
time not more than 10 s) avoided cardiopulmonary recir-reproducing an artificial recirculation in vitro with an
culation overlapping access recirculation. In clinical stud-appropriate circuit [8]. A monitor was equipped as for
ies, we used the same standard conditions as in vitro: QBa standard dialysis. The arterial line was connected to
300 mL/min, minimal ultrafiltration, arterial port dis-an outdated human blood bag, the venous line to a drain-
tance 50 cm.age bag.
With GIT, the access recirculation was calculated us-A short bypass line (priming 5 0.5 mL) linked the
ing equation 3 (discussed in the Results section), whereasends of the venous and arterial lines, reproducing in vitro
using the urea test, recirculation was obtained by thethe phenomenon of recirculation by a peristaltic pump
classic formula [9]:(BL 705; Bellco, Mirandola, Italy). The artificial recircu-
lation (RA) was then computed from the ratio between
R 5
(S 2 A)
(S 2 V)
3 100 (Eq. 1)the recirculation pump flow (QR) and the blood pump
flow (QB) gravimetrically calibrated using deionized wa-
ter (RA 5 QR 3 100/QB). where S represents the systemic urea obtained with the
The transit time of the glucose bolus at the venous stop-flow technique modified; A and V represent the
needle was evaluated by nine one-second withdrawals arterial and venous urea, with the blood pump running.
between 4 and 40 seconds after the start of the bolus To evaluate the reproducibility of the two tests, we
(three tests). The arterial passage of the recirculated repeated them twice on 17 patients in a short time (,20
glucose peak was evaluated by three prolonged with- min) so as to ensure comparable hemodynamic condi-
drawals in the intervals 8 to 12, 13 to 17, and 18 to 22 tions. The overall experience was therefore 56 paired
seconds from the arterial port (distance from the luer- GIT–urea tests (17 twice and 22 single).
lock 5 50 cm; three tests). Compared with the short Single urea determinations were done with a Hitachi
withdrawals, the longer time of sample B increases the 717 analyzer (Boehringer Mannheim, Monza, Italy).
catchment area of the recirculation peak, improving the
Statistical analysisreproducibility of the method.
The GIT was then tested with 0, 5, and 10% artificial The relationships between (B 2 A) values and artifi-
recirculation according to the protocol mentioned pre- cial recirculation (in vitro) and urea recirculation (in
viously in this article. vivo) were obtained by linear regression analysis.
Blood glucose was measured in triplicate by a reflec- To correctly separate the positive and negative cases
tance photometer (One Touch II Hospital; Lifescan, Milpi- with GIT, it was important to establish whether the dif-
tas, CA, USA) using a glucose oxidase enzymatic method. ference between B and A really existed or was due to
The reproducibility of the photometer was verified on a instrument imprecision. To check the significance of this
wide range of values (CV 1.8%). For glucose values out difference statistically, the 95% confidence intervals (62
of the range (.600 mg/100 mL), the determinations were SD) for each triplet of A and B were obtained. B was
repeated after a 1:3 dilution with saline. really different from A when the 95% confidence inter-
vals did not overlap. We could also derive the upper and
In vivo validation lower confidence limits of (B 2 A), respectively (Bmax 2
We verified the arterial kinetics of the recirculation Amin) and (Bmin 2 Amax), and finally, by applying equation
peak in vivo by three prolonged withdrawals from the 3 to these two values of (B 2 A), we obtained the 95%
arterial port in the intervals 8 to 12, 13 to 17, and 18 confidence intervals of GIT%. GIT was positive (recircu-
to 22 seconds in 10 patients with very different needle lation present) when the lower confidence limit of GIT%
positions. In 39 chronic hemodialysis patients with sus- was more than zero.
pected (32 out of 39) or forced (7 out of 39) recirculation For the urea test, we estimated theoretical 95% confi-
(obtained by reversing the blood lines at the needles), dence intervals (Appendix) of samples S, V, and A, and
the GIT and urea test were compared consecutively. then obtained the confidence intervals for urea recircula-
Thirty-one had autogenous fistulae (20 forearm and tion.
We tested the reproducibility of GIT and urea test by11 upper arm), one polytetrafluoroethylene graft upper
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Table 1. In vitro validation (N 5 30)
QB QR RA B 2 A CV
mL/min % mg/100 mL %
300 0 0 20.1761.6 —
300 15 5 108.769.9 9.1
300 30 10 213.5619 8.9
Abbreviations are: QB, blood flow; QR, recirculation blood flow; RA, artificial
recirculation; B 2 A, D glucose; CV, coefficient of variation.
Fig. 1. In vitro glucose peak with nine one-second withdrawals from
the end of the venous blood line (N 5 27).
repeating each test twice on 17 patients. The standard
deviation of paired GIT was determined, and then we
averaged SDGIT by pooling the individual (SDi) of the N
individual patients (Ni):
Fig. 2. Relationship between artificial recirculation (RA%) and glucose
increase (B – A) in vitro (N 5 30). The regression equation calculatesPooled SD 5 !S(SDi)
2
Ni
(Eq. 2)
RA percentage from (B – A) values (y 5 0.046x 1 0.07; r 5 0.99).
From the pooled SDGIT, we obtained the coefficient
R 5 0.046 3 (B 2 A) 1 0.07 (Eq. 3)of variation (CV% 5 pooled SD 3 100/mean) for GIT.
A similar analysis was done for GIT in vitro and urea with a close correlation (r 5 0.99; Fig. 2). Using equation
test in vivo. 3, we can derive the recirculation percentages directly
Normally distributed data were analyzed by Student’s from the (B 2 A) values. We had 100% specificity and
paired t-test. sensitivity (no false positive or false negative), and good
reproducibility with a (B 2 A) pooled SD of 12.4 mg/
100 mL and averaged CV of 11.6%.RESULTS
In vitro In vivo
Figure 1 shows the transit time of the glucose bolus in The in vivo arterial glucose recirculation peak was
the dialytic circuit. At the venous needle, blood glucose between 13 and 17 seconds from the start of the bolus.
increased after six to eight seconds from the start of the The kinetics of the glucose bolus was as follows: 10 sec-
bolus (time for the glucose to mix in the blood volume onds to reach the peak at the venous needle and another
of the drip chamber and cover the venous line), quickly 5 seconds to reach the arterial port in case of recircula-
peaked (between 8 and 12 s), than slowly dropped back tion. After a further 10 to 20 seconds (25 to 35 s from
to the basal value in 40 to 50 seconds. The drip chamber the start of the bolus), there was another small increase
volume acted as a glucose level equalizer, reducing the in the arterial glucose level caused by cardiopulmonary
variability of the manual bolus. recirculation.
The recirculation peak was taken from the arterial We evaluated the relationship between the urea test
port between 13 and 17 seconds. This time was crucial and the increase in blood glucose with GIT (Fig. 3). The
for an accurate GIT measurement, and depended on the correlation was strong (r 5 0.93), showing that GIT also
blood pump flow and arterial port distance. Our data really measured recirculation in vivo. Moreover, we de-
refer to a standard situation (QB 300 mL/min and port rived recirculation percentages by applying equation 3
at 50 cm). Other QB and port distances need different to (B 2 A) values (the mean GIT is 8.3% and the mean
timing. urea test is 9.9%). According to GIT results, the patients
Table 1 shows the mean values of (B 2 A) correspond- were divided into two groups: with recirculation (22 out
ing to artificial recirculation of 0, 5, and 10% (N 5 30). of 39, mean GIT 5 11.8%) or without (17 out of 39,
mean GIT 5 0.06%; Table 2). The urea test did notThe regression equation is:
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Fig. 4. Comparison of paired tests (GIT and UT) in 17 patients. The
better reproducibility (GIT1 5 GIT2) gives D results (GIT1 – GIT2) nearFig. 3. Linear regression between recirculation measured with the urea
to zero. Symbols are: (j) D GIT%; (h) D UT%.test (ARUT) and glucose increase (B – A) with GIT (N 5 56; y 5
0.048x 1 1.3; r 5 0.93).
Table 4. True positive cases: Reversed blood lines
Table 2. In vivo validation: Comparison GIT 2 UT (N 5 39)
GIT UT
B2A GIT S2A UTARUT
Cases mg/100 mL % 95% CI mg/100 mL % 95% CI
Absent Present
1 346 16 15.1 16.9 15.0 21.6 11.9 32.8Patients (#10%) (.10%)
6 782 36 34.7 37.3 62.0 34.5 25.2 45.4
Absent (#0.3%) 17 17 0 10 74 3.5 3.0 4.0 7.0 (6.3) 23.8 17.8ARGIT Present (.0.3%) 22 7 15 11 160 18.3 17.8 18.9 8.5 16 6.2 27.3
13 257 11.9 11.3 12.6 6.5 17.4 7.6 28.6Abbreviations are: ARGIT, access recirculation measured by GIT; GIT, glucose
14 60 2.8 2.6 3.1 0.5 (1.1) 29.2 12.7infusion test; UT, urea test; ARUT, access recirculation by UT.
33 310 14.3 13.8 14.8 27.5 24.1 14.5 35.2
All values are means of two results (cases repeated twice).
CI is 95% confidence interval (See Appendix).
Values in parentheses are not different from zero (false negative) becauseTable 3. Discordant cases: Comparison of GIT and UT results
CI , 0.
GIT UT
B2A GIT S2A
Cases mg/100 mL % 95% CI mg/100 mL UT% 95% CI
3 134 6.2 6.0 6.5 10 (7.7) 22.4 19.1
values were near to zero (mean D 1%), whereas urea test5a 178.5 8.3 7.7 10.8 8 (6.7) 23.4 18.2
8a 9.5 0.5 0.2 0.9 2.5 (2.9) 27.3 14.4 differences were more dispersed (mean D 5.5%; Fig. 4).
10a 74 3.5 3.0 4.0 7 (6.3) 23.8 17.8
12a 160 7.4 7.1 7.8 8.5 (8.7) 21.3 20.1
14a 60 2.8 2.6 3.1 0.5 (1.1) 29.2 12.7 DISCUSSION20 182 8.4 7.8 9.0 7 (7.4) 22.7 18.8
The urea test is still the most widespread method usedB2A is D glucose with GIT; S2A is D urea with UT. CI 5 95% confidence
interval. Values in parentheses are not different from zero because 95% CI , 0. for assessing of vascular access recirculation despite its
Cases 10 and 14 are true positives because of recirculation forced by reversing
limitations and difficulties [6, 7]. The main limitation isthe blood lines.
aAverage of paired tests inaccurate detection of recirculation under 10% because
of the small differences between systemic and arterial
urea values (S 2 A; Eq. 1), which are hard to detect by
laboratory tests [10–12]. Look, for example, at the casesrecognize 7 out of 22 patients with positive GIT because
with forced recirculation (true positives) in Table 4. Thethe lower confidence limit was negative (Table 3) and
urea test failed to detect recirculation in cases 10 and 14the urea recirculation (mean 5.5%, range 1.1 to 8.7%)
because of the small difference between samples S andwas under the threshold of 10% according to the litera-
A (respectively 7 and 0.5 mg/100 mL of urea correspond-ture [10–12] and our data (Appendix). Similar percent-
ing to a recirculation of 6.3 and 1.1%). These differencesages for GIT (mean GIT 5.3%, range 0.5 to 8.4%) were
are not significant because the 95% lower confidencecertainly positive (GIT threshold 0.3%; Appendix). De-
limits are negative. With GIT, we had a wider and reli-spite similar analytical errors (urease CV 5 1.9%; glu-
ably detected B 2 A differences (in the same cases,cose oxidase CV 5 1.8%) GIT was more sensitive than
74 and 60 mg/100 mL of glucose corresponding to athe urea test.
recirculation of 3.5 and 2.8%). The low recirculations inFinally, GIT showed better reproducibility (pooled
these cases were surprising, but they were particularSD 0.7%, CV 8.6%) than the urea test (pooled SD 4.6%;
CV 45.4%). The differences (D) of each pair of GIT situations: Case 10 had a central venous catheter, and
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case 14 a proximal fistula with very close needles (3 cm), difficulties because it does not require a pump or venous
samples, and it is not contaminated by the cardiopulmo-neither one facing the blood stream. These particular
situations caused incomplete mixing of the reversed nary recirculation.
In conclusion, the GIT is a practical possibility forblood flow and hence the low recirculations. The urea
test showed 71% sensitivity with two false negatives inexpensive and accurate vascular access screening that
could replace the classic urea test. Further studies are(cases 10 and 14) out of seven, whereas GIT gave 100%
sensitivity. We verified the specificity of the two tests in necessary particularly to verify the formula for GIT cal-
culation (Eq. 3) in a wider range of clinical cases. It willfive cases in which true negatives obtained by inserting
the venous needle in the opposite arm (in two cases the be interesting to compare GIT with the new dilution
methods and to establish other procedures in differentarterial line was connected to a femoral vein catheter).
Both methods gave 100% specificity, verifying the ab- operative conditions (QB 200 to 400 mL/min).
sence of access recirculation in all cases, but GIT gave
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The GIT, on the other hand, showed high sensitivity
both in vitro and in vivo, with a minimal limit of detection APPENDIX
of 0.3% because of the large arteriovenous difference Estimate of the theoretical 95% confidence interval (CI) for the
caused by the glucose bolus. The repeatability was also urea test (UT)
better with GIT than with the urea test (CV 8.6 and For urea we have only single measurements. To calculate the 95%
CI of UT, we measured the laboratory error in urea determinations45.4%).
at three levels (mean urea values of 55, 112, 145 mg/100 mL, N 5 15),Glucose is an ideal tracer because it is harmless and obtaining a pooled SD of 2 mg/100 mL and an average CV of 1.9%.
easy to measure. For a few seconds, the peak of glucose From the average CV, we can approximate the SD of each single
measure and then derive the theoretical 95% CI (6 2 SD). For example,in the venous line reaches 1200 to 1400 mg/100 mL and
in venous samplesquickly drops as soon as it is mixed with the fistula blood
Vmax 5 V 1 2SD 5 V 1 (2CV/100 3 V)flow. This peak does not cause hemolysis, local pain or
inflammation, or other discomfort to the patient. Within 5 V 3 (1 1 2CV/100) 5 V 3 1.038 (Eq. 4)
five to six minutes, glucose returns to the basal value Vmin 5 V 2 2SD 5 V 2 (2CV/100 3 V)
(even in diabetic patients) because of hemodilution and
5 V 3 (1 2 2CV/100) 5 V 3 0.962 (Eq. 5)dialysis.
Similar for S and A.While other methods are partially automated [1–3],
Using these values in equation 1, we can calculate the theoreticalGIT needs a precise protocol and standard conditions, 95% CI of UT:
but its simplicity and accuracy far outweigh these limita-
UTmin 5
(Smin 2 Amax)
(Smax 2 Vmin)
3 100 (Eq. 6)tions.
The rapid bolus and prolonged withdrawal (B) play a
major role in the good results. The bolus infusion gives UTmax 5
(Smax 2 Amin)
(Smin 2 Vmax)
3 100 (Eq. 7)
a very high and rapid blood glucose peak that can dis-
Recirculation is present when the UTmin percentage is . 0.criminate very small percentages of recirculation and
separate it from the cardiopulmonary recirculation. The Estimate of UT and GIT limit of detection
longer time (4 s) for sample B improves the reproducibil- We related the UT results with the derived UTMIN obtaining the
regression equationsity of the method, as it averages the glucose increase
and catches the recirculated peak even in very different UTmin 5 1.03 UT 2 10.3 (Eq. 8)
operating conditions (that is, with a needle distance vary-
Considering the test positive when UTmin . 0, from equation 8 we caning from 3 to 15 cm). calculate the limit of detection for UT as 10%. A similar analysis can
be made for GIT with:Other authors have suggested continuous glucose infu-
sion as a measurement of recirculation (abstract; Yamaji GITmin 5 0.97 GIT 2 0.3 (Eq. 9)
et al, J Am Soc Nephrol 8:176A, 1997). This approach is From equation 9, we can calculate the limit of detection for GIT, which
more complicated than GIT because it needs an infusion is 0.3%.
pump and a distal venous port to take venous samples; it
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